Mehak Chopra, NP
Psychiatric/Mental Health · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Mehak Chopra’s office at (888) 731-8984 to ask if they take your plan before you enroll.
Medicaid work
$4,422 in 2023
Medicaid paid $4,422 for 347 billed services this clinician did in 2023, up to 98 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 79 | $2,436 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 87 | $1,430 |
| Psychiatric diagnostic evaluation with medical services | 13 | $518 |
| Return visit (30+ min) | 168 | $38 |
| 2023 | 347 | 4 | 98 | $4,422 |
| 2022 | 54 | 2 | 28 | $0 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 26 | $0 |
| Return visit (30+ min) | 28 | $0 |
Drugs they prescribed that Part D paid
$27,556
Pharmacies billed $27,556 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
118 generic and 14 brand-name prescriptions · $27,556 in drug cost · 22 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 12 | $18,911 | $1,576 |
| Sertraline | 17 | $74 | $4 |
Year by year
| 2024 | 132 | 39 | None | 11% | $27,556 |
| 2023 | 539 | 93 | None | None | $161,901 |
| 2022 | 341 | 121 | 6% (19) | None | $1,073,572 |
| 2021 | 50 | 21 | 28% (14) | None | $122,317 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Lurasidone | 13 | $8,616 | $663 |
| Aripiprazole | 11 | $1,718 | $156 |
| Quetiapine | 30 | $1,122 | $37 |
| Anastrozole | 25 | $1,001 | $40 |
| Bupropion Xl | 37 | $979 | $26 |
| Duloxetine | 34 | $687 | $20 |
| Trazodone | 27 | $638 | $24 |
| Lamotrigine | 27 | $394 | $15 |
| Albuterol Sulfate Hfa | 11 | $390 | $35 |
| Escitalopram | 37 | $369 | $10 |
| Sertraline | 29 | $270 | $9 |
| Hydroxyzine | 23 | $270 | $12 |
| Mirtazapine | 24 | $182 | $8 |
| Buspirone | 11 | $59 | $5 |
2022: 10 drugs
| Imbruvica | 21 | $325,989 | $15,523 |
| Xtandi | 13 | $206,665 | $15,897 |
| Eliquis | 20 | $15,145 | $757 |
| Anastrozole | 30 | $1,136 | $38 |
| Tamoxifen Citrate | 17 | $412 | $24 |
| Ondansetron | 25 | $361 | $14 |
| Hydrocodone-Acetaminophen | 15 | $317 | $21 |
| Hydroxyurea | 23 | $316 | $14 |
| Acyclovir | 11 | $298 | $27 |
| Levothyroxine | 11 | $84 | $8 |
Money from drug and device companies
$68 in 2025
| 2025 | 2 | 3 | None | $68 |
| 2024 | 6 | 7 | None | $172 |
| 2023 | 11 | 14 | None | $302 |
| 2022 | 42 | 140 | None | $2,861 |
| 2021 | 49 | 274 | None | $4,550 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Epkinly | $46 | 2 payments
|
| GlaxoSmithKline | Jemperli | $21 | 1 payment
|
See all 3 published payments
| GlaxoSmithKline | Meals · 2025-12-01 | Jemperli | $21 |
| Abbvie | Meals · 2025-12-01 | Epkinly | $28 |
| Abbvie | Meals · 2025-03-11 | Epkinly | $19 |
See earlier years (2024, 2023, 2022, 2021)
2024: $172
| Abbvie | Imbruvica | $49 | 2 payments
|
| Verity Pharmaceuticals | Trelstar | $29 | 1 payment
|
| Celgene | Pomalyst | $28 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $24 | 1 payment
|
| Recordati Rare Diseases Inc. | Sylvant | $24 | 1 payment
|
| Daiichi Sankyo | Enhertu | $19 | 1 payment
|
2023: $302
| Daiichi Sankyo | Enhertu | $57 | 2 payments
|
| Novartis Pharmaceuticals | Pluvicto | $45 | 2 payments
|
| Celgene | Pomalyst | $37 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $25 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $24 | 1 payment
|
| Pharmacyclics LLC An AbbVie | Epkinly | $23 | 1 payment
|
| Gilead Sciences | Trodelvy | $22 | 1 payment
|
| Abbvie | Venclexta | $19 | 1 payment
|
| Octapharma USA | Panzyga | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $17 | 1 payment
|
| Accord Healthcare | Camcevi | $17 | 1 payment
|
2022: $2,861
| E.R. Squibb & Sons L.L.C. | Opdivo | $288 | 16 payments
|
| Incyte | Jakafi | $270 | 8 payments
|
| Janssen Biotech | Erleada | $208 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $191 | 10 payments
|
| Novartis Pharmaceuticals | Mekinist | $156 | 12 payments
|
| Amgen | Nplate | $144 | 6 payments
|
| Merck Sharp & Dohme | Keytruda | $119 | 6 payments
|
| Rigel Pharmaceuticals | Tavalisse | $104 | 5 payments
|
| Karyopharm Therapeutics | Xpovio | $97 | 5 payments
|
| Gilead Sciences | Trodelvy | $95 | 5 payments
|
| Daiichi Sankyo | Enhertu | $90 | 4 payments
|
| Celgene | Pomalyst | $86 | 4 payments
|
| Seagen | Tukysa | $76 | 4 payments
|
| Pfizer | Inlyta | $72 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $70 | 3 payments
|
| Lilly USA | Verzenio | $56 | 3 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $55 | 2 payments
|
| Puma Biotechnology | Nerlynx | $55 | 3 payments
|
| BeiGene USA | Brukinsa | $54 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $46 | 2 payments
|
| TerSera Therapeutics | Xermelo | $42 | 2 payments
|
| Genzyme | Jevtana | $42 | 2 payments
|
| Myovant Sciences | Orgovyx | $40 | 2 payments
|
| Octapharma USA | Panzyga | $33 | 2 payments
|
| AVEO Pharmaceuticals | Fotivda | $29 | 1 payment
|
| Exelixis | Cabometyx | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $26 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $26 | 1 payment
|
| GE HealthCare | None | $24 | 1 payment
|
| G1 Therapeutics | Cosela | $24 | 1 payment
|
| Kyowa Kirin | Poteligeo | $24 | 1 payment
|
| PharmaEssentia USA | Besremi | $22 | 1 payment
|
| EUSA Pharma (US) | Sylvant | $22 | 1 payment
|
| ADC Therapeutics America | None | $21 | 1 payment
|
| Global Blood Therapeutics | Oxbryta | $20 | 1 payment
|
| Taiho Oncology | Lonsurf | $19 | 1 payment
|
| Genentech USA | Tecentriq | $17 | 1 payment
|
| Acrotech Biopharma | Beleodaq | $17 | 1 payment
|
| Alnylam Pharmaceuticals | Givlaari | $15 | 1 payment
|
| Sobi | Gamifant | $14 | 1 payment
|
| Astellas Pharma US | Xtandi | $14 | 1 payment
|
| Emmaus Medical | Endari | $12 | 1 payment
|
2021: $4,550
| Amgen | Kyprolis | $507 | 17 payments
|
| Janssen Biotech | Imbruvica | $384 | 15 payments
|
| Novartis Pharmaceuticals | Mekinist | $289 | 17 payments
|
| Seagen | Padcev | $257 | 10 payments
|
| Merck Sharp & Dohme | Keytruda | $234 | 11 payments
|
| Astellas Pharma US | Xtandi | $212 | 6 payments
|
| Lilly USA | Cyramza | $185 | 13 payments
|
| Genzyme | Sarclisa | $153 | 8 payments
|
| GlaxoSmithKline | Blenrep | $150 | 6 payments
|
| Alexion Pharmaceuticals | Ultomiris | $146 | 4 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $134 | 7 payments
|
| Celgene | Onureg | $122 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $115 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $112 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $105 | 6 payments
|
| Sanofi-Aventis U.S. | Elitek | $100 | 1 payment
|
| Puma Biotechnology | Nerlynx | $99 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $98 | 3 payments
|
| EMD Serono | None | $96 | 6 payments
|
| Rigel Pharmaceuticals | Tavalisse | $78 | 4 payments
|
| BeiGene USA | Brukinsa | $74 | 3 payments
|
| Daiichi Sankyo | Enhertu | $68 | 3 payments
|
| MorphoSys US | Monjuvi | $64 | 3 payments
|
| Pfizer | Ibrance | $59 | 3 payments
|
| Karyopharm Therapeutics | Xpovio | $57 | 3 payments
|
| Deciphera Pharmaceuticals | Qinlock | $55 | 3 payments
|
| Dova Pharmaceuticals | Doptelet | $49 | 2 payments
|
| AbbVie | Venclexta | $44 | 3 payments
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $44 | 2 payments
|
| Eisai | Lenvima | $43 | 2 payments
|
| Global Blood Therapeutics | Oxbryta | $40 | 2 payments
|
| Foundation Medicine | Foundationone | $33 | 2 payments
|
| Sobi | Gamifant | $33 | 1 payment
|
| Genentech USA | Tecentriq | $31 | 2 payments
|
| Blueprint Medicines | Gavreto | $28 | 1 payment
|
| Novocure | Optune | $27 | 1 payment
|
| Aveo Pharmaceuticals | Fotivda | $24 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $24 | 1 payment
|
| Exelixis | Cabometyx | $22 | 1 payment
|
| Coherus Biosciences | Udenyca | $22 | 1 payment
|
| EUSA Pharma (US) | Sylvant | $21 | 1 payment
|
| Kite Pharma | Yescarta | $18 | 1 payment
|
| Myovant Sciences | Orgovyx | $17 | 1 payment
|
| Servier Pharmaceuticals | Tibsovo | $16 | 1 payment
|
| Agios Pharmaceuticals | Tibsovo | $15 | 1 payment
|
| Myriad Genetic Laboratories | Mychoice Cdx | $15 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $13 | 1 payment
|
| Ge Healthcare | None | $11 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $7 | 1 payment
|
Professional record
- NPI
- 1447854633
- Licence
- CA NP95015913
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2020-11-28
- NPI last updated
- 2025-10-08
- NPI record certified
- 2025-10-08
This is when the NPI record was last certified, not a medical board exam.